China Universal Asset Management »

United Therapeutics Corporation shares owned by China Universal Asset Management

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.1M 9.0k 229.76
2023-12-31 $1.2M 5.4k 219.97
2023-09-30 $270k 1.2k 225.56
2023-06-30 $136k 615 221.14
2023-03-31 $141k 628 224.52
2022-12-31 $129k 463 278.62
2022-09-30 $89k 426 208.92

More positions owned by China Universal Asset Management

Microsoft Corp Common Stock (MSFT)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Meta Platforms Inc-class A Common Stock (META)
Vertex Pharmaceuticals Common Stock (VRTX)
Amgen Common Stock (AMGN)
Servicenow Common Stock (NOW)
Gilead Sciences Common Stock (GILD)
Regeneron Pharmaceuticals Common Stock (REGN)
Alphabet Inc-cl A Common Stock (GOOGL)
Adobe Common Stock (ADBE)
Broadcom Common Stock (AVGO)
Visa Inc-class A Shares Common Stock (V)
Apple Common Stock (AAPL)
Uber Technologies Common Stock (UBER)

View all positions for China Universal Asset Management

Top funds holding United Therapeutics Corporation

Vanguard Group
Wellington Management Company
venBio Select Advisor
Henderson Group
Citigroup
Dimensional Fund Advisors
AQR Capital Management
LSV Asset Management
Pacer Advisors
Bank of New York Mellon
Norges Bank Investment Management
Charles Schwab Investment Management
Palo Alto Investors
OrbiMed Advisors
Nordea Investment Management Ab

View all funds holding United Therapeutics Corporation